Statement Of Changes In Equity [Abstract]

Affluent Medical - Filing #882835

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity
43 535 EUR
10,000 EUR
55 207 EUR
43 535 EUR
80 546 EUR
22,000 EUR
18 164 EUR
- EUR
- EUR
35 290 EUR
15 257 EUR
22,000 EUR
21,000 EUR
62 683 EUR
35 290 EUR
42 649 EUR
30 964 EUR
- EUR
24,000 EUR
47 701 EUR
30 964 EUR
20,000 EUR
28 641 EUR
11 900 EUR
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)
- EUR
14 820 EUR
- EUR
- EUR
- EUR
14 820 EUR
- EUR
14 820 EUR
14 319 EUR
- EUR
14 319 EUR
- EUR
- EUR
- EUR
- EUR
14 319 EUR
Other comprehensive income
- EUR
33,000 EUR
32,000 EUR
- EUR
1,000 EUR
- EUR
- EUR
33,000 EUR
5,000 EUR
2,000 EUR
- EUR
- EUR
3,000 EUR
- EUR
- EUR
5,000 EUR
Comprehensive income
- EUR
14 787 EUR
32,000 EUR
- EUR
1,000 EUR
14 820 EUR
- EUR
14 787 EUR
14 324 EUR
2,000 EUR
14 319 EUR
- EUR
3,000 EUR
- EUR
- EUR
14 324 EUR
Issue of equity
- EUR
23 000 EUR
- EUR
20 326 EUR
- EUR
- EUR
2 674 EUR
23 000 EUR
7 611 EUR
- EUR
- EUR
1 292 EUR
- EUR
- EUR
6 319 EUR
7 611 EUR
Increase (decrease) through treasury share transactions, equity
- EUR
372,000 EUR
- EUR
- EUR
- EUR
372,000 EUR
- EUR
372,000 EUR
Increase (decrease) through share-based payment transactions, equity
- EUR
42,000 EUR
- EUR
- EUR
- EUR
42,000 EUR
- EUR
42,000 EUR
959,000 EUR
- EUR
959,000 EUR
- EUR
- EUR
- EUR
- EUR
959,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.